Therapeutic oligonucleotides – Medicines of the future
About OligoNova
OligoNova is a Swedish initiative addressing challenges in Research & Development of therapeutic oligonucleotides and supporting the development of novel therapies. OligoNova has the vision to deliver R&D innovations that will result in new patents, start-up companies and innovate treatments to patients.
What we offer
From target to preclinical “in vitro PoC”
Part of SciLifeLab DDD platform
From preclinical “in vitro PoC” to preclinical PoC/early clinical evaluation
Innovative science collaborations
National scientific network on oligonucleotide research
Multimedia
A short presentation of OligoNova and the power of therapeutic oligonucleotides
News
OligoNova Hub appoints
new scientific director
More about OligoNova
OligoNova was initiated by the University of Gothenburg and AstraZeneca in 2020…
OligoNova 